1. Market Research
  2. > Yakult Honsha Co., Ltd. - Product Pipeline Review - 2013

Yakult Honsha Co., Ltd. - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 54 pages

Yakult Honsha Co., Ltd. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Yakult Honsha Co., Ltd. - Product Pipeline Review - 2013” provides data on the Yakult Honsha Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Yakult Honsha Co., Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Yakult Honsha Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Yakult Honsha Co., Ltd. - Brief Yakult Honsha Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Yakult Honsha Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Yakult Honsha Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Yakult Honsha Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Yakult Honsha Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Yakult Honsha Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Yakult Honsha Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Yakult Honsha Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Yakult Honsha Co., Ltd. and identify potential opportunities in those areas.

Table Of Contents

Yakult Honsha Co., Ltd. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Yakult Honsha Co., Ltd. Snapshot 5
Yakult Honsha Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Yakult Honsha Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Yakult Honsha Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Yakult Honsha Co., Ltd. - Pipeline Products Glance 12
Yakult Honsha Co., Ltd. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Yakult Honsha Co., Ltd. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Yakult Honsha Co., Ltd. - Drug Profiles 15
doxorubicin liposomal 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
perifosine 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
resminostat 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
pegylated liposomal irinotecan hydrochloride 25
Product Description 25
Mechanism of Action 25
RandD Progress 25
PR-509 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
PR-610 27
Product Description 27
Mechanism of Action 27
RandD Progress 27
Yakult Honsha Co., Ltd. - Pipeline Analysis 28
Yakult Honsha Co., Ltd. - Pipeline Products by Therapeutic Class 28
Yakult Honsha Co., Ltd. - Pipeline Products by Target 29
Yakult Honsha Co., Ltd. - Pipeline Products by Route of Administration 30
Yakult Honsha Co., Ltd. - Pipeline Products by Molecule Type 31
Yakult Honsha Co., Ltd. - Pipeline Products by Mechanism of Action 32
Yakult Honsha Co., Ltd. - Recent Pipeline Updates 33
Yakult Honsha Co., Ltd. - Dormant Projects 47
Yakult Honsha Co., Ltd. - Discontinued Pipeline Products 48
Discontinued Pipeline Product Profiles 48
adozelesin 48
Yakult Honsha Co., Ltd. - Company Statement 49
Yakult Honsha Co., Ltd. - Locations And Subsidiaries 50
Head Office 50
Other Locations and Subsidiaries 50
Yakult Honsha Co., Ltd. - Key Manufacturing Facilities 52
Appendix 53
Methodology 53
Coverage 53
Secondary Research 53
Primary Research 53
Expert Panel Validation 53
Contact Us 54
Disclaimer 54



List of Tables

Yakult Honsha Co., Ltd., Key Information 5
Yakult Honsha Co., Ltd., Key Facts 5
Yakult Honsha Co., Ltd. - Pipeline by Indication, 2013 7
Yakult Honsha Co., Ltd. - Pipeline by Stage of Development, 2013 8
Yakult Honsha Co., Ltd. - Monotherapy Products in Pipeline, 2013 9
Yakult Honsha Co., Ltd. - Partnered Products in Pipeline, 2013 10
Yakult Honsha Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2013 11
Yakult Honsha Co., Ltd. - Phase III, 2013 12
Yakult Honsha Co., Ltd. - Phase II, 2013 13
Yakult Honsha Co., Ltd. - Phase I, 2013 14
Yakult Honsha Co., Ltd. - Pipeline by Therapeutic Class, 2013 28
Yakult Honsha Co., Ltd. - Pipeline by Target, 2013 29
Yakult Honsha Co., Ltd. - Pipeline by Route of Administration, 2013 30
Yakult Honsha Co., Ltd. - Pipeline by Molecule Type, 2013 31
Yakult Honsha Co., Ltd. - Pipeline Products by Mechanism of Action, 2013 32
Yakult Honsha Co., Ltd. - Recent Pipeline Updates, 2013 33
Yakult Honsha Co., Ltd. - Dormant Developmental Projects,2013 47
Yakult Honsha Co., Ltd. - Discontinued Pipeline Products, 2013 48
Yakult Honsha Co., Ltd., Subsidiaries 50
Yakult Honsha Co., Ltd., Key Manufacturing Facilities 52



List of Figures

Yakult Honsha Co., Ltd. - Pipeline by Top 10 Indication, 2013 7
Yakult Honsha Co., Ltd. - Pipeline by Stage of Development, 2013 8
Yakult Honsha Co., Ltd. - Monotherapy Products in Pipeline, 2013 9
Yakult Honsha Co., Ltd. - Partnered Products in Pipeline, 2013 10
Yakult Honsha Co., Ltd. - Pipeline by Top 10 Therapeutic Class, 2013 28
Yakult Honsha Co., Ltd. - Pipeline by Top 10 Target, 2013 29
Yakult Honsha Co., Ltd. - Pipeline by Top 10 Route of Administration, 2013 30
Yakult Honsha Co., Ltd. - Pipeline by Top 10 Molecule Type, 2013 31
Yakult Honsha Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2013 32



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.